Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...

The hormone insulin plays a central role in the metabolism of many living organisms. When food is plentiful, insulin promotes ...

What's the most attractive weight-loss stock right now? We asked Seeking Alpha analysts Edmund Ingham, Stephen Ayers and Oneil Trader for their picks. Read more here.

Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Unless you live under a rock, you’ve heard about injectable GLP-1 agonist drugs like ...

Rising prevalence of diabetes, recent product approvals & product launches in the market are the major factors driving the market for incretin-based drugs.

The extent to which newer, incretin-based drugs for obesity improve disease outcomes via weight loss versus the direct ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

An experimental drug called amycretin showed signs it could be more potent than Eli Lilly’s rival Zepbound, though analysts ...

Altimmune, Inc. (NASDAQ:ALT), a biopharmaceutical company with a market capitalization of $503.56 million focused on ...

Urge your mayor to take action on climate change by joining the Earth Hour City Challenge! To avoid the worst effects of climate change, we need to dramatically reduce global carbon emissions. But we ...

Lake-effect snow brings heavy snowfall to some parts of North America Lake-effect snow is most common around the Great Lakes region in the US and Canada during late autumn and winter. It can lead ...